Seminars in Thrombosis and Hemostasis

Seminars in Thrombosis and Hemostasis is an international, peer-reviewed medical review journal devoted to the biology, diagnosis, prevention, and treatment of disorders involving thrombosis and hemostasis. The journal was established in 1974 and is published by Thieme Medical Publishers. Rather than functioning primarily as a venue for routine original research papers, it is structured around authoritative reviews and thematic coverage of developments relevant to hematologists, thrombosis specialists, coagulation researchers, laboratory professionals, and clinicians in related fields. Its subject area encompasses the mechanisms that produce pathological blood clotting, the normal and abnormal processes that control bleeding, and the clinical use of laboratory and therapeutic approaches in these areas. Topics associated with the journal's scope include coagulation factors, platelet biology, anticoagulant and antiplatelet treatment, inherited and acquired bleeding disorders, venous and arterial thromboembolism, laboratory testing, thrombophilia, hemostatic agents, and emerging developments in vascular and hematological medicine. The review format allows the publication to synthesize findings from across the specialist literature and place new techniques, therapies, and controversies in a broader clinical and scientific context. The journal is issued eight times per year. Its principal offering is the continuing journal series itself, delivered through the academic publishing infrastructure of Thieme in print and electronic formats. The publication serves a specialist international readership rather than a general consumer audience, and its value proposition is based on editorial expertise, peer review, topical synthesis, and discoverability within medical and scientific information systems. Seminars in Thrombosis and Hemostasis has maintained a distinct identity within the hematology and vascular-medicine literature since its launch. Its title signals both the clinical and laboratory dimensions of its coverage: thrombosis concerns pathological clot formation, while hemostasis concerns the mechanisms that prevent and control bleeding. This dual focus gives the journal relevance across multiple medical specialties and supports thematic issues that connect basic mechanisms with diagnosis and patient care. The journal is edited by Emmanuel J. Favaloro, who is identified as its editor-in-chief in the available reference material. Its publication by Thieme Medical Publishers places it within an established specialist medical publishing house. The journal's 2018 Journal Citation Reports impact factor was reported as 3.401; this historical metric should not be treated as its current citation performance. No reliable information in the supplied material establishes a separate corporate headquarters, ownership structure beyond its publisher relationship, or a current financial valuation. The available evidence supports describing Seminars in Thrombosis and Hemostasis as an active specialist academic journal brand.

Seminars in Thrombosis and Hemostasis was founded in 1974 as a specialist medical journal addressing the mechanisms and clinical consequences of abnormal clotting and bleeding. Its subject area sits within hematology but also overlaps with vascular medicine, transfusion medicine, laboratory diagnostics, pharmacology, and internal medicine. From its inception, the journal's title established a deliberately paired scope: thrombosis concerns unwanted clot formation, whereas hemostasis concerns the physiological systems that stop bleeding and the disorders that impair them. The publication operates primarily as a review journal. Its role is to consolidate and interpret scientific and clinical literature rather than simply provide a sequence of narrowly focused primary research reports. This format is particularly useful in a fast-changing field in which new anticoagulants, antiplatelet agents, laboratory assays, genetic findings, and treatment guidelines can alter professional practice. Review-based coverage also enables the journal to address foundational biology alongside diagnosis, risk assessment, prevention, and treatment. Thieme Medical Publishers publishes the journal. Over time, Seminars in Thrombosis and Hemostasis has developed as part of the specialist medical and scientific publishing ecosystem, serving readers who require detailed, curated information on coagulation and related disorders. Its audience includes clinical hematologists, thrombosis specialists, laboratory scientists, researchers, and physicians in fields that manage thrombotic or bleeding complications. The journal is published eight times annually. Its continuing publication schedule and specialist scope distinguish it from a one-off reference work or a general medical periodical. The journal's principal product is the recurring scholarly publication, supported by thematic editorial planning and peer review. Available reference material identifies Emmanuel J. Favaloro as editor-in-chief, although the supplied sources do not establish the date of his appointment or provide a complete chronology of earlier editors. The publication's historical performance has been represented through bibliometric indicators. Journal Citation Reports recorded an impact factor of 3.401 for 2018. That figure is tied to the specified reporting year and should not be generalized to later editions. The available material does not provide sufficient evidence for a detailed account of later impact factors, circulation, subscription revenue, ownership changes, mergers, controversies, or discontinued editions. On the evidence available, the journal remains an active Thieme medical publication with an international scholarly readership.

• 2018

  Reported impact factor

  [1]Seminars in Thrombosis and Hemostasisen.wikipedia.org

  Journal Citation Reports recorded a 2018 impact factor of 3.401 for the journal.

• 1974

  Journal established

  [1]Seminars in Thrombosis and Hemostasisen.wikipedia.org

  Seminars in Thrombosis and Hemostasis was established as a peer-reviewed specialist journal covering thrombosis, hemostasis, and related hematology.

A specialist, peer-reviewed review journal positioned at the intersection of hematology, coagulation science, thrombosis medicine, and clinical laboratory practice.

• Peer-reviewed medical review journal · 1974

  Seminars in Thrombosis and Hemostasis

  The journal's core and apparently sole branded offering is a specialist review publication focused on thrombosis, hemostasis, and associated hematological disorders. It publishes curated, peer-reviewed synthesis for clinicians and researchers, covering subjects such as coagulation biology, platelet function, bleeding disorders, thromboembolic disease, laboratory investigation, and antithrombotic treatment. The journal is published eight times per year by Thieme Medical Publishers and is intended for an international professional readership.

1. 1Seminars in Thrombosis and Hemostasisen.wikipedia.org
2. 2Seminars in Thrombosis and Hemostasis journal informationthieme.de